Currently, limited data are available regardingFuzuloparib overdose, and the specific symptoms are not fully defined.
According to existing records, a small number of patients who received a daily dose of 450 mg did not experience unexpected adverse reactions.
In the event of suspected overdose, close monitoring for abnormal signs is required, with prompt symptomatic and supportive care administered as needed.
